The Association of Low Molecular Weight Heparin Use and In-hospital Mortality Among Patients Hospitalized with COVID-19.

Lan ShenLin QiuDong LiuLi WangHengye HuangHeng GeYing XiaoYi LiuJingjin JinXiulan LiuDao Wen WangEric D PetersonBen HeNing Zhou

Published in: Cardiovascular drugs and therapy (2021)

Among hospitalized COVID-19 patients, LMWH use was associated with lower all-cause in-hospital mortality than non-LMWH users. The survival benefit was particularly significant among more severely ill patients.

Keyphrases

sars cov
end stage renal disease
coronavirus disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
venous thromboembolism
growth factor
respiratory syndrome coronavirus
free survival
patient reported